← FDA Drug Approvals (Drugs@FDA)

OLMESARTAN MEDOXOMIL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CADILA PHARMS LTD · Approved 2024-11-08

Drug application

FDA Application #

ANDA210682

Application type

Abbreviated New Drug Application (Generic)

Brand name

OLMESARTAN MEDOXOMIL

Generic name

OLMESARTAN MEDOXOMIL

Active ingredients

OLMESARTAN MEDOXOMIL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

CADILA PHARMS LTD

Manufacturer

Modavar Pharmaceuticals LLC

First approval

2024-11-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown